Watch for Shares of Bristol-Myers Squibb (BMY) to Approach Support at $30.45Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ tra…
Selecta Biosciences Initiates Phase 1 Clinical Study of SEL-068, a First-in …MarketWatch (press release)Examples for applications include autoimmune diseases, allergies and transplant rejection. Selecta's pipeline currently contains a vaccine for…
The GuardianMending heartsThe GuardianIt went on to fund research into overcoming transplant rejection, a problem that halted transplants until the late 1970s. In 1976, BHF Professor Michael Davies demonstrated that blood clots cause heart attacks. Thi…
NASDAQ Volume Active Stocks are – ASML, ALXN, COCO, TKLC, VRUSRetirement Planning… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeuti…
Adage Capital's Top Q3 Healthcare Sector Stock HoldingsWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psyc…
Low Ferritin Levels Associated With Better Prognosis After Stem Cell …The MDS Beacon… the study's five years follow-up time; 43 percent died of disease relapse or disease progression and 57 percent died of other causes, including infection, org…
Bristol-Myers Squibb (BMY) Approaches New Downside Target of $30.53Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant r…
NASDAQ Hot Stocks to Keep an Eye on – CERN, ALXN, QGEN, VCLK, ACLSRetirement Planning… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therap…
Pharmacy Practice NewsHard Work Pays Off: 2011 ASHP Lit Awards To Be Given at MidyearPharmacy Practice NewsThe resulting study showed no significant differences in the rate of acute rejection, graft loss or death between 115 renal transplant patients w…
The Diabetic Foot menace!Modern GhanaAmong the events leading to failure of a tissue, or 'Organ-transplant-rejection', is usually an infection. Dr. Washkansky had a diabetic foot, which was infected in addition, even at the time of the transpla…